-transparent.png){kind=logo}
The administration of metoclopramide (MET) increased human pancreatic polypeptide (hPP) levels in 17 of 18 male and female control subjects. In all the control subjects, the increase was from a mean (+/- SD) basal level of 96 +/- 60 pg/ml, to a peak of 221 +/- 170 pg/ml. The peak occurred at 30 min, and levels had decreased by 60 min in all subjects. Atropine pretreatment in five male control subjects significantly decreased basal hPP levels and completely abolished the response to MET. It thus likely that the hPP increase consequent to MET administration is related to the latter's cholinergic properties.
Related Publications
I M Spitz, and
E Zylber, and
J Jersky, and
D Leroith
July 1978,
Lancet (London, England),
I M Spitz, and
E Zylber, and
J Jersky, and
D Leroith
January 1981,
Journees annuelles de diabetologie de l'Hotel-Dieu,
I M Spitz, and
E Zylber, and
J Jersky, and
D Leroith
April 1985,
Scandinavian journal of gastroenterology,
I M Spitz, and
E Zylber, and
J Jersky, and
D Leroith
September 1981,
The Journal of clinical endocrinology and metabolism,
I M Spitz, and
E Zylber, and
J Jersky, and
D Leroith
December 2019,
Neuro endocrinology letters,
I M Spitz, and
E Zylber, and
J Jersky, and
D Leroith
January 1979,
Digestive diseases and sciences,
I M Spitz, and
E Zylber, and
J Jersky, and
D Leroith
January 1978,
The Journal of clinical endocrinology and metabolism,
I M Spitz, and
E Zylber, and
J Jersky, and
D Leroith
January 1984,
The Tohoku journal of experimental medicine,
I M Spitz, and
E Zylber, and
J Jersky, and
D Leroith
January 1988,
Digestion,
I M Spitz, and
E Zylber, and
J Jersky, and
D Leroith
October 1980,
The American journal of gastroenterology,
